Department of Urology, Uludag University, Gorukle, Bursa, Turkey.
Bosn J Basic Med Sci. 2011 Aug;11(3):158-62. doi: 10.17305/bjbms.2011.2567.
Many pharmacological agents were investigated for the prevention of renal ischemic reperfusion (I/R) injury as well as the phosphodiesterase (PDE) inhibitors. The aim of the study was to examine the possible renoprotective effect of a member in this family, tadalafil (Td) on I/R injury. Thirty-six Spraque Dawley rats were allocated to six groups as; control, sham, ischemia (I), ischemia/reperfusion (I/R), Td pretreatment ischemia (Td/I) and Td pretreatment ischemia/reperfusion (Td/IR) groups. Right nephrectomy was performed in all groups. Td was dissolved in saline solution and given as a single dose (1mg/kg) through an orogastrictube 60 min before the operation in the Td pretreatment groups. In ischemia group the left renal pedicle was occluded for 45 minutes and after than underwent left nephrectomy. In I/R group left renal pedicle was occluded for 45 minutes, reperfused for 1hour and after then underwent nephrectomy. The left kidneys were evaluated after standard laboratory procedures with regard to tubular morphology, and leukocyte infiltration. The data were analyzed by using Kruskal-Wallis test to determine differences among the groups. A p value of < 0.05 was considered significant. Renal tubular damage was significant increased in the ischemia and I/R group (Groups III and IV) when compared to those in the sham group (Group II), (p = 0.004, 0.004, respectively). Tubular damage, in the Td pretreatment ischemia (Td/I) (Group V) and Td pretreatment ischemia/reperfusion (Td/IR) (Group VI) were less than that in the ischemia group (Group III) (p= 0.010, p= 0.025, respectively). Td administration prior to the renal I/R injury attenuated these morphological disarrangements, which were observed in renal I/R. Tubular necrosis, which may be considered as an important issue of the developing renal injury, was also completely prevented with Td administration.
许多药理学药物被研究用于预防肾缺血再灌注(I/R)损伤以及磷酸二酯酶(PDE)抑制剂。本研究的目的是研究该家族成员之一他达拉非(Td)对 I/R 损伤的可能肾保护作用。将 36 只 Spraque Dawley 大鼠分为 6 组:对照组、假手术组、缺血组(I)、缺血/再灌注组(I/R)、他达拉非预处理缺血组(Td/I)和他达拉非预处理缺血/再灌注组(Td/IR)。所有组均进行右肾切除术。在 Td 预处理组中,将 Td 溶解在生理盐水中,并通过经口胃管在手术前 60 分钟给予单次剂量(1mg/kg)。在缺血组中,左侧肾蒂被阻断 45 分钟,然后进行左肾切除术。在 I/R 组中,左侧肾蒂被阻断 45 分钟,再灌注 1 小时,然后进行肾切除术。在标准实验室程序后,用肾小管形态和白细胞浸润来评估左肾。数据采用 Kruskal-Wallis 检验进行分析,以确定组间差异。p 值<0.05 被认为具有统计学意义。与假手术组(组 II)相比,缺血组(组 III)和 I/R 组(组 IV)的肾小管损伤明显增加(p=0.004,0.004)。与缺血组(组 III)相比,他达拉非预处理缺血组(组 V)和他达拉非预处理缺血/再灌注组(组 VI)的肾小管损伤更小(p=0.010,p=0.025)。在肾 I/R 损伤前给予 Td 可减轻肾 I/R 引起的这些形态学紊乱。用 Td 给药也完全防止了肾小管坏死,这可能是肾损伤发展的一个重要问题。